Moderna: Lab study confirms its COVID-19 vaccine still protects against new variants
Source: MarketWatch - Jaimy Lee Mon, January 25, 2021, 7:55 AM
Shares of Moderna Inc. gained 4.6% in premarket trading on Monday afer the company said laboratory studies demonstrated that its COVID-19 vaccine can still protect people against two new coronavirus variants: the B.1.1.7 that was first identified in the United Kingdom, and the B.1.351 strain, out of South Africa. The study was not conducted in humans. The findings were released in a news release, and the company said it expects the results to be published in preprint form.
Moderna said the in-vitro studies showed that the B.1.1.7 variant had no "significant" impact on neutralizing antibody titers developed as a result of vaccination; however, they also demonstrated that the vaccine was less effective against the B.1.351 variant. In this case,
the vaccine still produced levels of neutralizing antibody titers that were protective, but the titer levels were lower....CONTINUED....
Read More:https://www.yahoo.com/finance/m/acc7dc7e-8a18-3471-b8da-154e54666b8e/moderna-lab-study-confirms.html
________________________________________________________________________________________________________
Good news!!!